A Phase 1 Clinical Trial to Evaluate the Plasma Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Zoliflodacin in Healthy Male and Female Subjects
Phase of Trial: Phase I
Latest Information Update: 01 Jun 2018
At a glance
- Drugs Zoliflodacin (Primary)
- Indications Gonorrhoea
- Focus Pharmacokinetics
- 06 Apr 2018 Status changed from active, no longer recruiting to completed.
- 08 Mar 2018 Status changed from not yet recruiting to active, no longer recruiting.
- 01 Feb 2018 Planned initiation date changed from 17 Jan 2018 to 14 Feb 2018.